🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Status
Completed
Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Start Date
2022-07-05
Trial ID
NCT05415215
Observational investigation of participants who are given neoadjuvant treat...
Status
Not Yet Recruiting
Location
National Institute of Oncolgy
Start Date
2022-03
Trial ID
NCT05131893
The purpose of this trial is to evaluate efficacy and toxicity of either th...
Status
Active Not Recruiting
Location
Dept. of Oncology, Örebro University Hospital
Start Date
2014-11
Trial ID
NCT02568839
Treatments Being Tested
This 3 arm study will assess the tolerability, safety and efficacy of 3 neo...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT00976989
Treatments Being Tested
The goal of this clinical trial is to compare trastuzumab deruxtecan (T-DXd...
Status
Recruiting
Location
Skåne University Hospital
Start Date
2023-10-26
Trial ID
NCT05900206
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This is a randomized, open label Phase II neoadjuvant study comparing the e...
Status
Unknown
Location
ShengJing ospital of China Medical University
Start Date
2021-10-20
Trial ID
NCT05483439
Breast cancer is the most common malignant tumor in women. EC-TH is one of ...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2019-01-10
Trial ID
NCT04172259
The study is being conducted to assess the efficacy and safety of anthracyc...
Status
Unknown
Location
Breast Oncology, Tianjin Medical University Cancer Institute and Hospital
Start Date
2022-10-08
Trial ID
NCT05871918
Treatments Being Tested
This is a phase 2 study evaluating medical treatment before surgery in HER2...
Status
Terminated
Location
Sahlgrenska universitetssjukhuset
Start Date
2019-05-23
Trial ID
NCT03894007